Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Nitrogen containing other than solely as a nitrogen in an...
Patent
1993-10-20
1995-01-10
Reamer, James H.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Nitrogen containing other than solely as a nitrogen in an...
424449, A61K 31135
Patent
active
053807618
ABSTRACT:
An anhydrous transdermal composition is disclosed comprising in a 20 to 100% lyotropic liquid crystalline arrangement:
REFERENCES:
patent: 4861800 (1989-08-01), Buyske
patent: 4868218 (1989-09-01), Buyske
patent: 5053227 (1991-10-01), Chiang et al.
patent: 5096612 (1992-03-01), Pinter et al.
New Nematic Phase In Lyotropic Binary Liquid Crystals Detected By Position Annihilation Techniques-1986, vol. 136, pp. 153-166.
Die Pharmazeutische Industrie, Pharm. Ind. 40,3, pp. 256-261 (1978).
Arch Gen Psychiatry-vol. 44, May 1987; pp. 427-433; P. N. Tariot et al; `L-Deprenyl in Alzheimer's Disease`.
Psychopharmacology (1987) 91, pp. 489-495; P. N. Tariot et al `Cognitive effects of L-deprenyl in Alzheimer's disease`.
Clinical Neuropharmacology; vol. 13, No. 2. pp. 147-163 (1990) `Neuropsychological Effects of L-Deprenyl in Alzheimer's Type . . . `.
Pharmacopsychiat, 20 (1987) pp. 256-257; E. Martini et al `Brief Information on an Early Phase-II-Study With Deprenyl . . . `.
Journal of Controlled Release, 13 (1990) pp. 73-81; Tiemessen et al; `Probing the Microstructure of Liquid Crystalline Surfactant . . . `.
Biochemical Pharmacology, 1963, vol. 12; pp. 1417-1419; R. J. Wurtman et al; `Sex Steroids, Cardiac H-Norepinephrine . . . `.
Medical Biology vol. 54; pp. 137-141; (1976) A. Wiberg et al `Quantitative Aspects On Mitochondrial Monoamine Oxidase In . . . `.
Muszaki Konyvkiado 1986, pp. 107-110.
Merck Index, 10th Ed., Compounds 7545, 7555.
Sigma Catalog of Biochemicals and Organic Compounds, p. 290 (1992).
Cremophor.RTM. EL, BASF.
Myritol 318.sup.r, Henkel.
Science; vol. 245; pp. 519-522, Aug. 4, 1989; James W. Tetrud and J. M. Langston; `The Effect of Deprenyl (Selegiline) on the . . . `.
New England Journal of Medicine; Nov. 16, 1989; pp. 1364-1371; `Effect of Deprenyl On the Progression of Disability In Early . . . `.
Acta Neurol Scand 1983: Suppl 95; pp. 103-105; W. Birkmayer; `Deprenyl (selegiline) in the treatment of Parkinson's disease`.
Lengyel Jozsef
Magyar Kalman
Marmarosi (nee Kellner) Katalin
Pinter Janos
Szabo nee Ujhelyi Gabriella
Chinoin Gyogyszer- es Vegyeszeti Termekek Gyara RT.
Dubno Herbert
Myers Jonathan
Reamer James H.
LandOfFree
Transdermal compositions does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Transdermal compositions, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Transdermal compositions will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-851007